The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Primary biliary cirrhosis: A 2010 update
Open accessAbstract
Primary biliary cirrhosis (PBC) is a chronic inflammatory autoimmune disease that mainly targets the cholangiocytes of the interlobular bile ducts in the liver. The condition primarily affects middle-aged women. Without treatment, PBC generally progresses to cirrhosis and eventually liver failure over a period of 10-20 years. PBC is a rare disease with prevalence of less than 1/2000. PBC is thought to result from a combination of multiple genetic factors and superimposed environmental triggers. The contribution of the genetic predisposition is evidenced by the familial clustering. Several risk factors, including exposure to infectious agents and chemical xenobiotics, have been suggested. Ursodeoxycholic acid (UDCA) is currently the only FDA-approved medical treatment for PBC. When administered at doses of 13-15 mg/kg/day, a majority of patients with PBC have a normal life expectancy without additional therapeutic measures. One out of three patients does not adequately respond to UDCA therapy and may need additional medical therapy and/or liver transplantation. This review summarises current knowledge on the epidemiology, ethiopathogenesis, clinical, and therapeutic aspects of PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007) · Hepatology · doi:10.1002/hep.21907 · Cited by 1,722
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Self-citationModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755
Self-citationChazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746 · cited 1×
“, presence of two of the three of the following features: (1) ALT activity P5 times upper limits of normal; (2) IgG P2 times upper limits of normal and/or positive anti–smooth muscle antibody; and (3) liver biopsy with moderate or severe periportal or periseptal inflammation [158,159,165].”
BackgroundSelf-citationPoupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Self-citationBiochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Corpechot, C., Abenavoli, L., Rabahi, N., Chrétien, Y., Andréani, T., Johanet, C., Chazouillères, O., & Poupon, R. (2008) · Hepatology · doi:10.1002/hep.22428 · Cited by 646 · cited 2×
“The survival rate of UDCA-treated patients in early stages of disease is similar to that in a control population [142,143].”
BackgroundResultSelf-citationGershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594
Gershwin, M. E., Mackay, I. R., Sturgess, A., & Coppel, R. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3525 · Cited by 557
ARE STEROID INHALERS SAFER THAN TABLETS?
Morrow Brown, H., Jackson, F. A., & Herxheimer, H. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91347-3 · Cited by 516
SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
WALKER, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91372-3 · Cited by 507
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment
Selmi, C., Mayo, M. J., Bach, N., Ishibashi, H., Invernizzi, P., Gish, R. G., Gordon, S. C., Wright, H. I., Zweiban, B., Podda, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.005 · Cited by 480
Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., et al. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.010 · Cited by 464
Kuiper, E. M. M., Hansen, B. E., de Vries, R. A., den Ouden–Muller, J. W., van Ditzhuijsen, T. J. M., Haagsma, E. B., Houben, M. H. M. G., Witteman, B. J. M., van Erpecum, K. J., & van Buuren, H. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.003 · Cited by 460
IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS
Foulis, A., Farquharson, M., & Meager, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91128-7 · Cited by 446
AHRENS, E. H., PAYNE, M. A., KUNKEL, H. G., EISENMENGER, W. J., & BLONDHEIM, S. H. (1950) · Medicine · doi:10.1097/00005792-195012000-00002 · Cited by 436
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
Corpechot, C., Carrat, F., Bahr, A., Chrétien, Y., Poupon, R.-E., & Poupon, R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.009 · Cited by 390
Self-citationPRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.
Rubin, E., Schaffner, F., & Pópper, H. (1965) · PubMed Central · Cited by 374
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
Epidemiology and natural history of primary biliary cirrhosis in a U.S. community
Kim, W. R., Lindor, K. D., Locke, G. R., Therneau, T. M., Homburger, H. A., Batts, K. P., Yawn, B. P., Petz, J. L., Melton, L. J., & Dickson, E. R. (2000) · Gastroenterology · doi:10.1053/gast.2000.20197 · Cited by 349
Prince, M., Chetwynd, A., Newman, W., Metcalf, J. V., & James, O. F. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.36027 · Cited by 348
Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y., Choi, S. S., Witek, R. P., Alpini, G., Venter, J., Vandongen, H. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 341
Serum bilirubin: a prognostic factor in primary biliary cirrhosis
Shapiro, J. M., Smith, H., & Schaffner, F. (1979) · Gut · doi:10.1136/gut.20.2.137 · Cited by 319
Corpechot, C., Carrat, F., Bonnand, A.-M., Poupon, R. E., & Poupon, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20240 · Cited by 316
Self-citationPatients With Primary Biliary Cirrhosis React Against A Ubiquitous Xenobiotic–Metabolizing Bacterium
Selmi, C., Balkwill, D. L., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S., Kenny, T. P., Van De Water, J., Nantz, M. H., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50446 · Cited by 312
Proliferating Cholangiocytes: A Neuroendocrine Compartment in the Diseased Liver
Alvaro, D., Mancino, M. G., Glaser, S., Gaudio, E., Marzioni, M., Francis, H., & Alpini, G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.07.023 · Cited by 304
PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS
Yeaman, S. J., Danner, D. J., Mutimer, D. J., Fussey, S. P. M., James, O. F. W., & Bassendine, M. F. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91894-6 · Cited by 293
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.-U., Zatloukal, K., Denk, H., & Trauner, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275
Christensen, E., Crowe, J., Doniach, D., Popper, H., Ranek, L., Rodés, J., Tygstrup, N., & Williams, R. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90571-5 · Cited by 273
Frequency of monosomy X in women with primary biliary cirrhosis
Invernizzi, P., Miozzo, M., Battezzati, P. M., Bianchi, I., Grati, F. R., Simoni, G., Selmi, C., Watnik, M., Gershwin, M. E., & Podda, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15541-4 · Cited by 268
Jacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J. L., James, O. F. W., & Jones, D. E. J. (2005) · Gut · doi:10.1136/gut.2005.065862 · Cited by 267
Impact of fatigue on the quality of life of patients with primary biliary cirrhosis
Huet, P.-M., Deslauriers, J., Tran, A., Faucher, C., & Charbonneau, J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01857.x · Cited by 262
Hirschfield, G. M., & Heathcote, E. J. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch32 · Cited by 261
Leuschner, M., Maier, K., Schlichting, J., Strahl, S., Herrmann, G., Dahm, H. H., Ackermann, H., Happ, J., & Leuschner, U. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70351-3 · Cited by 247
Fatigue in primary biliary cirrhosis
Cauch-Dudek, K., Abbey, S., Stewart, D. E., & Heathcote, E. J. (1998) · Gut · doi:10.1136/gut.43.5.705 · Cited by 237
Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
Angulo, P., Batts, K. P., Therneau, T. M., Jorgensen, R. A., Dickson, R. E., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510290301 · Cited by 234
Liver Autoimmunity Triggered by Microbial Activation of Natural Killer T Cells
Mattner, J., Savage, P. B., Leung, P., Oertelt, S. S., Wang, V., Trivedi, O., Scanlon, S. T., Pendem, K., Teyton, L., Hart, J., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.009 · Cited by 224
Does a betaretrovirus infection trigger primary biliary cirrhosis?
Xu, L., Shen, Z., Guo, L., Fodera, B., Keogh, A., Joplin, R., O'Donnell, B., Aitken, J., Carman, W., Neuberger, J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433063100 · Cited by 223
Rautiainen, H., Kärkkäinen, P., Karvonen, A., Nurmi, H., Pikkarainen, P., Nuutinen, H., & Färkkilä, M. (2005) · Hepatology · doi:10.1002/hep.20646 · Cited by 222
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites
Ala, A., Stanca, C. M., Bu-Ghanim, M., Ahmado, I., Branch, A. D., Schiano, T. D., Odin, J. A., & Bach, N. (2006) · Hepatology · doi:10.1002/hep.21076 · Cited by 222
Kinnman, N., Francoz, C., Barbu, V., Wendum, D., Rey, C., Hultcrantz, R., Poupon, R., & Housset, C. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000054178.01162.e4 · Cited by 222
Self-citationOdin, J. A., Huebert, R. C., Casciola-Rosen, L., LaRusso, N. F., & Rosen, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200110716 · Cited by 220
D'Aldebert, E., Biyeyeme Bi Mve, M., Mergey, M., Wendum, D., Firrincieli, D., Coilly, A., Fouassier, L., Corpechot, C., Poupon, R., Housset, C., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.040 · Cited by 219
Self-citationPrimary biliary cirrhosis once rare, now common in the United Kingdom?
James, O. F., Bhopal, R., Howel, D., Gray, J., Burt, A. D., & Metcalf, J. V. (1999) · Hepatology · doi:10.1002/hep.510300213 · Cited by 213
Familial primary biliary cirrhosis reassessed: a geographically-based population study
Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F., & James, O. F. W. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80097-x · Cited by 213
A Controlled Trial of Cyclosporine in the Treatment of Primary Biliary Cirrhosis
Wiesner, R. H., Ludwig, J., Lindor, K. D., Jorgensen, R. A., Baldus, W. P., Homburger, H. A., & Dickson, E. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222003 · Cited by 212
Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis
Poupon, R. E., Bonnand, A.-M., Chrétien, Y., & Poupon, R. (1999) · Hepatology · doi:10.1002/hep.510290603 · Cited by 209
Self-citationDecreased Anion Exchanger 2 Immunoreactivity in the Liver of Patients With Primary Biliary Cirrhosis
Medina, J. F., Martínez-Ansó, E., Vázquez, J. J., & Prieto, J. (1997) · Hepatology · doi:10.1002/hep.510250104 · Cited by 207
Hepatic IL-17 responses in human and murine primary biliary cirrhosis
Lan, R. Y. Z., Salunga, T. L., Tsuneyama, K., Lian, Z.-X., Yang, G.-X., Hsu, W., Moritoki, Y., Ansari, A. A., Kemper, C., Price, J., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.11.001 · Cited by 202
The true impact of fatigue in primary biliary cirrhosis: A population study
Goldblatt, J., Taylor, P. J. S., Lipman, T., Prince, M. I., Baragiotta, A., Bassendine, M. F., James, O. F. W., & Jones, D. E. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32993 · Cited by 202
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002) · Gut · doi:10.1136/gut.50.3.436 · Cited by 202
Salas, J. T., Banales, J. M., Sarvide, S., Recalde, S., Ferrer, A., Uriarte, I., Oude Elferink, R. P. J., Prieto, J., & Medina, J. F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.020 · Cited by 195
Autoimmune hepatitis with incidental histologic features of bile duct injury
Czaja, A. J., & Carpenter, H. A. (2001) · Hepatology · doi:10.1053/jhep.2001.27562 · Cited by 189
Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
Charlotte, F., L’Herminé, A. C., Martin, N., Geleyn, Y., Nollet, M., Gaulard, P., & Zafrani, E. (1994) · PubMed Central · Cited by 188
Time course of histological progression in primary biliary cirrhosis
Locke, G. R., Therneau, T. M., Ludwig, J., Dickson, E. R., & Lindor, K. D. (1996) · Hepatology · doi:10.1002/hep.510230108 · Cited by 184 · cited 1×
“750 Journal of Hepatology 201 median time to develop extensive fibrosis was 2 years and the probability of remaining in the early stage was 29% (95% confidence interval: 15–52%) after 4 years of follow-up [133,135,136].”
BackgroundHarada, K., Shimoda, S., Sato, Y., Isse, K., Ikeda, H., & Nakanuma, Y. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03947.x · Cited by 180
Wakabayashi, K., Lian, Z., Leung, P. S. C., Moritoki, Y., Tsuneyama, K., Kurth, M. J., Lam, K. S., Yoshida, K., Yang, G., Hibi, T., et al. (2008) · Hepatology · doi:10.1002/hep.22390 · Cited by 180
Van de Water, J., Turchany, J., Leung, P. S., Lake, J., Munoz, S., Surh, C. D., Coppel, R., Ansari, A., Nakanuma, Y., & Gershwin, M. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116504 · Cited by 179
Irie, J., Wu, Y., Wicker, L. S., Rainbow, D., Nalesnik, M. A., Hirsch, R., Peterson, L. B., Leung, P. S. C., Cheng, C., Mackay, I. R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051911 · Cited by 179
Tandon, P., Rowe, B. H., Vandermeer, B., & Bain, V. G. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01200.x · Cited by 176
Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England
Metcalf, J., Bhopal, R., Gray, J., Howel, D., & James, O. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.4.830 · Cited by 176
Degott, C., Zafrani, E. S., Callard, P., Balkau, B., Poupon, R. E., & Poupon, R. (1999) · Hepatology · doi:10.1002/hep.510290444 · Cited by 174
Self-citationGores, G. J., Wiesner, R. H., Dickson, E. R., Zinsmeister, A. R., Jorgensen, R. A., & Langworthy, A. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90526-x · Cited by 173
Rieger, R., Leung, P. S. C., Jeddeloh, M. R., Kurth, M. J., Nantz, M. H., Lam, K. S., Barsky, D., Ansari, A. A., Coppel, R. L., Mackay, I. R., et al. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.06.002 · Cited by 172
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis
Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology · doi:10.1002/hep.21229 · Cited by 170
Self-citationCorpechot, C., Carrat, F., Poupon, R., & Poupon, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.31880 · Cited by 169
Self-citationBile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J. H., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 167
Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis
Lindor, K. D., Jorgensen, R. A., Therneau, T. M., Malinchoc, M., & Dickson, E. R. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.12.1137 · Cited by 166
The geographical distribution of primary biliary cirrhosis in a well-defined cohort
Prince, M. I., Chetwynd, A., Diggle, P., Jarner, M., Metcalf, J. V., & James, O. F. W. (2001) · Hepatology · doi:10.1053/jhep.2001.29760 · Cited by 166
Khurana, S., & Singh, P. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01326.x · Cited by 162
Long, S. A., Quan, C., Van de Water, J., Nantz, M. H., Kurth, M. J., Barsky, D., Colvin, M. E., Lam, K. S., Coppel, R. L., Ansari, A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2956 · Cited by 161
ter Borg, P. C. J., Schalm, S. W., Hansen, B. E., & van Buuren, H. R. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00699.x · Cited by 160
Isse, K., Harada, K., Zen, Y., Kamihira, T., Shimoda, S., Harada, M., & Nakanuma, Y. (2005) · Hepatology · doi:10.1002/hep.20582 · Cited by 158
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis
Czaja, A. J., Carpenter, H. A., & Manns, M. P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90160-e · Cited by 155
Mita, S., Suzuki, H., Akita, H., Hayashi, H., Onuki, R., Hofmann, A. F., & Sugiyama, Y. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008748 · Cited by 155
Alpini, G. D., Baiocchi, L., Glaser, S. S., Ueno, Y., Marzioni, M., Francis, H., Phinizy, J. L., Angelico, M., & LeSage, G. (2002) · Hepatology · doi:10.1053/jhep.2002.32712 · Cited by 154
Lombard, M. G., Portmann, B., Neuberger, J., Williams, R. L., Tygstrup, N., Ranek, L., Ring‐Larsen, H., Rodés, J., Navasa, M., TREPO, C. G., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90422-9 · Cited by 153
Transplantation trends in primary biliary cirrhosis
Lee, J., Belanger, A., Doucette, J. T., Stanca, C., Friedman, S., & Bach, N. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.07.015 · Cited by 147
Characterization of antimitochondrial antibodies in healthy adults
Mattalia, A., Quaranta, S., Leung, P. S. C., Bauducci, M., Van de Water, J., Calvo, P. L., Danielle, F., Rizzetto, M., Ansari, A., Coppel, R. L., et al. (1998) · Hepatology · doi:10.1002/hep.510270303 · Cited by 146
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology · doi:10.1002/hep.22380 · Cited by 146
Iwasaki, S., Ohira, H., Nishiguchi, S., Zeniya, M., Kaneko, S., Onji, M., Ishibashi, H., Sakaida, I., Kuriyama, S., Ichida, T., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00305.x · Cited by 145
Kinnman, N., Hultcrantz, R. W., Barbu, V., Rey, C., Wendum, D., Poupon, R. Y., & Housset, C. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780073 · Cited by 145
Self-citationBerg, P. A., Lindenborn-Fotinos, J., Klein, R., & Klöppel, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91327-7 · Cited by 144
Quality of life in patients with primary biliary cirrhosis
Poupon, R. E., Chrétien, Y., Chazouillères, O., Poupon, R., & Chwalow, J. (2004) · Hepatology · doi:10.1002/hep.20276 · Cited by 144
Self-citationSasatomi, K., Noguchi, K., Sakisaka, S., Sata, M., & Tanikawa, K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80058-5 · Cited by 144
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis†
Miozzo, M. R., Selmi, C. F., Gentilin, B., Grati, F. R., Sirchia, S. M., Oertelt‐Prigione, S., Zuin, M. G., Gershwin, M. E., Podda, M., & Invernizzi, P. (2007) · Hepatology · doi:10.1002/hep.21696 · Cited by 142
Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis
Koga, H., Sakisaka, S., Ohishi, M., Sata, M., & Tanikawa, K. (1997) · Hepatology · doi:10.1002/hep.510250505 · Cited by 141
Sood, S., Gow, P. J., Christie, J. M., & Angus, P. W. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.064 · Cited by 140
The epidemiology of primary biliary cirrhosis
Prince, M. I., & James, O. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00102-8 · Cited by 140
Spirlì, C., Fabris, L., Duner, E., Fiorotto, R., Ballardini, G., Roskams, T., LaRusso, N. F., Sonzogni, A., Okolicsànyi, L., & Strazzabosco, M. (2003) · Gastroenterology · doi:10.1053/gast.2003.50100 · Cited by 138
Celli, A., Que, F. G., Gores, G. J., & LaRusso, N. F. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.4.g749 · Cited by 137
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., Denk, H., & Trauner, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01506.x · Cited by 137
Portmann, B. C., Pópper, H., Neuberger, J., & Williams, R. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90001-0 · Cited by 135
Assessment of biliary bicarbonate secretion in humans by positron emission tomography
Prìeto, J., García, N., Martí-Climent, J. M., Peñuelas, I., Richter, J. Á., & Medina, J. F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70564-0 · Cited by 135
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis
Alvaro, D., Invernizzi, P., Onori, P., Franchitto, A., De Santis, A., Crosignani, A., Sferra, R., Ginanni-Corradini, S., Grazia Mancino, M., Maggioni, M., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.022 · Cited by 134
Kruglov, E. A., Nathanson, R. A., Nguyễn, T. T., & Dranoff, J. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00308.2005 · Cited by 132
Shibao, K., Hirata, K., Robert, M. E., & Nathanson, M. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01201-0 · Cited by 131
An exploratory population-based case-control study of primary biliary cirrhosis
Howel, D., Fischbacher, C. M., Bhopal, R. S., Gray, J., Metcalf, J. V., & James, O. F. (2000) · Hepatology · doi:10.1053/he.2000.7050 · Cited by 131
Proinflammatory Cytokines Inhibit Secretion in Rat Bile Duct Epithelium
Spirlì, C., Nathanson, M. H., Fiorotto, R., Duner, E., Denson, L. A., Sanz, J. M., Virgilio, F. D., Okolicsànyi, L., Casagrande, F., & Strazzabosco, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.25516 · Cited by 129
Familial primary biliary cirrhosis
Bach, N., & Schaffner, F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80137-0 · Cited by 128
Combes, B., Emerson, S. S., Flye, N. L., Muñoz, S. J., Luketic, V. A., Mayo, M. J., McCashland, T. M., Zetterman, R. K., Peters, M. G., Bisceglie, A. M. D., et al. (2005) · Hepatology · doi:10.1002/hep.20897 · Cited by 126
Borchers, A. T., Shimoda, S., Bowlus, C. L., Keen, C. L., & Gershwin, M. E. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0167-2 · Cited by 125
Tsuneyama, K., de Water, J. V., Leung, P. S. C., Cha, S.-H., Nakanuma, Y., Kaplan, M., Lellis, R. D., Coppel, R. L., Ansari, A. A., & Gershwin, E. M. (1995) · Hepatology · doi:10.1002/hep.1840210422 · Cited by 124
Jung, Y., McCall, S. J., Li, Y., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21660 · Cited by 122
Danielsson, Å., Boqvist, L., & Uddenfeldt, P. (1990) · Hepatology · doi:10.1002/hep.1840110317 · Cited by 122
Genetic factors of susceptibility and of severity in primary biliary cirrhosis
Poupon, R. Y., Chen, P., Chrétien, Y., Corpechot, C., Chazouillères, O., Simon, T., Heath, S. C., Matsuda, F., Poupon, R. E., Housset, C., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.027 · Cited by 121
Self-citationLipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation
Chang, P., Lu, S., Su, T., Chou, S.-F., Huang, W.-H., Morrisett, J. D., Chen, C., Liau, C., & Lee, Y. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400229-jlr200 · Cited by 120
Yoshida, K., Yang, G., Zhang, W., Tsuda, M., Tsuneyama, K., Moritoki, Y., Ansari, A. A., Okazaki, K., Lian, Z., Coppel, R. L., et al. (2009) · Hepatology · doi:10.1002/hep.23132 · Cited by 119
Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group.
Watson, R. G., Angus, P., Dewar, M., Goss, B., Sewell, R. B., & Smallwood, R. A. (1995) · Gut · doi:10.1136/gut.36.6.927 · Cited by 119
Afford, S. C., Ahmed-Choudhury, J., Randhawa, S., Russell, C. L., Youster, J., Crosby, H. A., Eliopoulos, A. G., Hübscher, S. G., Young, L. S., & Adams, D. (2001) · The FASEB Journal · doi:10.1096/fj.01-0088com · Cited by 118
JONES, D. E. J., & NEWTON, J. L. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03223.x · Cited by 114
Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis
Tanaka, A., Lindor, K., Gish, R. G., Batts, K. P., Shiratori, Y., Omata, M., Nelson, L. J., Ansari, A. A., Coppel, R. L., Newsome, M., et al. (1999) · Hepatology · doi:10.1002/hep.510300410 · Cited by 114
de Water, J. V., Gerson, L. B., Ferrell, L. D., Lake, J. R., Coppel, R. L., Batts, K. P., Wiesner, R. H., & Gershwin, M. E. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008903379 · Cited by 114
Fiorotto, R., Spirlì, C., Fabris, L., Cadamuro, M., Okolicsànyi, L., & Strazzabosco, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.071 · Cited by 111
Portal Fibroblasts Regulate the Proliferation of Bile Duct Epithelia via Expression of NTPDase2
Jhandier, M. N., Kruglov, E. A., Lavoie, É. G., Sévigny, J., & Dranoff, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412371200 · Cited by 109
Cx3cl1 (Fractalkine): A Signpost for Biliary Inflammation in Primary Biliary Cirrhosis
Shimoda, S., Harada, K., Niiro, H., Taketomi, A., Maehara, Y., Tsuneyama, K., Kikuchi, K., Nakanuma, Y., Mackay, I. R., Gershwin, E. M., et al. (2010) · Hepatology · doi:10.1002/hep.23318 · Cited by 108
Selmi, C. F., Ross, S. R., Ansari, A. A., Invernizzi, P., Podda, M., Coppel, R. L., & Gershwin, M. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.033 · Cited by 108
Melero, S., Spirlì, C., Zsembery, Á., Medina, J. F., Joplin, R. E., Duner, E., Zuin, M., Neuberger, J. M., Prieto, J., & Strazzabosco, M. (2002) · Hepatology · doi:10.1053/jhep.2002.33634 · Cited by 107
Sakisaka, S., Kawaguchi, T., Taniguchi, E., Hanada, S., Sasatomi, K., Koga, H., Harada, M., Kimura, R., Sata, M., Sawada, N., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25086 · Cited by 106
Assessment of Biliary Bicarbonate Secretion in Humans by Positron Emission Tomography
Prìeto, J., García, N., Martí-Climent, J. M., Peñuelas, L., Richter, J. Á., & Medina, J. F. (2017) · Revista de medicina de la Universidad de Navarra · doi:10.15581/021.6810 · Cited by 106
Joplin, R., Strain, A. J., Neuberger, J., LINDSAY, J. G., & Johnson, G. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91001-o · Cited by 103
Matsumura, S., de Water, J. V., Leung, P. S. C., Odin, J. A., Yamamoto, K., Gores, G. J., Mostov, K. E., Ansari, A. A., Coppel, R. L., Shiratori, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20175 · Cited by 102
Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production†
Omenetti, A., Syn, W., Jung, Y., Francis, H., Porrello, A., Witek, R. P., Choi, S. S., Yang, L., Mayo, M. J., Gershwin, M. E., et al. (2009) · Hepatology · doi:10.1002/hep.23019 · Cited by 101
Induction of Primary Biliary Cirrhosis in Guinea Pigs following Chemical Xenobiotic Immunization
Leung, P. S. C., Park, O., Tsuneyama, K., Kurth, M. J., Lam, K. S., Ansari, A. A., Coppel, R. L., & Gershwin, M. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2651 · Cited by 100
Lindor, K. D., Dickson, R. E., Jorgensen, R. A., Anderson, M. L., Wiesner, R. H., Gores, G. J., Lange, S. M., Rossi, S. S., Hofmann, A. F., & Baldus, W. P. (1995) · Hepatology · doi:10.1016/0270-9139(95)90624-x · Cited by 99
Moritoki, Y., Lian, Z., Lindor, K. D., Tuscano, J. M., Tsuneyama, K., Zhang, W., Ueno, Y., Dunn, R., Kehry, M. R., Coppel, R. L., et al. (2009) · Hepatology · doi:10.1002/hep.23238 · Cited by 98
Marzioni, M., Alpini, G., Saccomanno, S., Candelaresi, C., Venter, J., Rychlicki, C., Fava, G., Francis, H., Trozzi, L., Glaser, S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.007 · Cited by 96 · cited 1×
“Among them, PPAR alpha agonists [187,188], FXR agonists [189] and biotherapies such as antiCD20 [190,191], GLP1 receptor agonists [192,193], and oestrogen-alpha receptor agonists [100] could be promising.”
BackgroundT cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis
Allina, J., Hu, B., Sullivan, D. M., Fiel, M. I., Thung, S. N., Bronk, S. F., Huebert, R. C., de Water, J. V., LaRusso, N. F., Gershwin, M. E., et al. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.11.004 · Cited by 96
IMMUNE PROCESSES IN THE PATHOGENESIS OF LIVER DISEASE*
Pópper, H., Paronetto, F., & Schaffner, F. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb19001.x · Cited by 93
Tanaka, A., Nezu, S., Uegaki, S., Kikuchi, K., Shibuya, A., Miyakawa, H., Takahashi, S.-I., Bianchi, I., Zermiani, P., Podda, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.015 · Cited by 91
On the role and fate of LPS-dephosphorylating activity in the rat liver
Tuin, A., der Vlag, A. H., van Loenen-Weemaes, A. M., Meijer, D. K. F., & Poelstra, K. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00147.2005 · Cited by 91
Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis
Poupon, R., Chazouillères, O., Balkau, B., & Poupon, R. E. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80098-1 · Cited by 90
Self-citationKaplan, M. M., Cheng, S., Price, L. L., & Bonis, P. A. L. (2004) · Hepatology · doi:10.1002/hep.20103 · Cited by 87
Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant
Vleggaar, F. P., van Buuren, H. R., Zondervan, P. E., ten Kate, F. J. W., Hop, W. C. J., & the Dutch Multicentre PBC study group (2001) · Gut · doi:10.1136/gut.49.2.276 · Cited by 87
Shimoda, S., Harada, K., Niiro, H., Yoshizumi, T., Soejima, Y., Taketomi, A., Maehara, Y., Tsuneyama, K., Nakamura, M., Komori, A., et al. (2008) · Hepatology · doi:10.1002/hep.22102 · Cited by 87
Familial Primary Biliary Cirrhosis in Hiroshima
Tsuji, K., Watanabe, Y., de Water, J. V., Nakanishi, T., Kajiyama, G., Parikh‐Patel, A., Coppel, R. L., & Gershwin, M. E. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0299 · Cited by 87
Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis
van Os, E., van den Broek, W. W., Mulder, P. G. H., ter Borg, P. C. J., Bruijn, J. A., & van Buuren, H. R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.036 · Cited by 87
Detection of male DNA in the liver of female patients with primary biliary cirrhosis
Fanning, P. A., Jonsson, J. R., Clouston, A. D., Edwards-Smith, C., Balderson, G. A., Macdonald, G. A., Crawford, D. H., Kerlin, P., Powell, L. W., & Powell, E. E. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80297-4 · Cited by 85
Wakabayashi, K., Yoshida, K., Leung, P. S. C., Moritoki, Y., Yang, G.-X., Tsuneyama, K., Lian, Z.-X., Hibi∥, T., Ansari, A. A., Wicker, L. S., et al. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03837.x · Cited by 82
Fetal microchimerism in primary biliary cirrhosis
Corpechot, C., Barbu, V. D., Chazouillères, O., & Poupon, R. Y. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80298-6 · Cited by 82
Self-citationGenetic factors in the pathogenesis of primary biliary cirrhosis
Jones, D. E. J., & Donaldson, P. T. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00095-3 · Cited by 82
Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis
Poupon, R. E., Ouguerram, K., Chrétien, Y., Verneau, C., Eschwège, É., Magot, T., & Poupon, R. Y. (1993) · Hepatology · doi:10.1002/hep.1840170408 · Cited by 80
Self-citationLakehal, F., Dansette, P. M., Becquemont, L., Lasnier, E., Delelo, R., Balladur, P., Poupon, R. Y., Beaune, P. H., & Housset, C. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002435 · Cited by 76
Self-citationA prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
Kaplan, M. M., Schmid, C. H., Provenzale, D., Sharma, A., Dickstein, G., & McKusick, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70403-8 · Cited by 74
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
Marzioni, M., Alpini, G., Saccomanno, S., Candelaresi, C., Venter, J., Rychlicki, C., Fava, G., Francis, H., Trozzi, L., & Benedetti, A. (2009) · Gut · doi:10.1136/gut.2008.150870 · Cited by 73
Autoimmune overlapping syndromes
Poupon, R. Y. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00092-8 · Cited by 73
Self-citationSchreuder, T. C. M. A., Hübscher, S. G., & Neuberger, J. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00729.x · Cited by 71
Walker, E. J., Hirschfield, G. M., Xu, C. D., Lü, Y., Liu, X., Lu, Y., Coltescu, C., Wang, K., Newman, W. G., Bykerk, V. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24412 · Cited by 71
Dysregulation of Apoptosis in the Cholangiopathies and Cholangiocarcinoma
Celli, A., & Que, F. G. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007153 · Cited by 71
Sadamoto, T., Joplin, R., Keogh, A., Mason, A. L., Carman, W. F., & Neuberger, J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)61042-2 · Cited by 71
Juran, B. D., Atkinson, E. J., Schlicht, E. M., Fridley, B. L., & Lazaridis, K. N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.077 · Cited by 69
Blood fetal microchimerism in primary biliary cirrhosis
Invernizzi, P., Andreis, C. D., Sirchia, S. M., Battezzati, P. M., Zuin, M. G., Rossella, F., Perego, F., Bignotto, M., Simoni, G., & Podda, M. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01381.x · Cited by 69
Rust, Sauter, Oswald, Büttner, Kullak‐Ublick, Paumgartner, & Beuers (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00606.x · Cited by 64
Stojaković, T., Claudel, T., Putz‐Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Sourij, H., Stauber, R. E., Winkler, K., März, W., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.052 · Cited by 63
Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment
Parés, A., & Guañabens, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.005 · Cited by 63
Pruritus in Primary Biliary Cirrhosis: Pathogenesis and Therapy
Bergasa, N. V. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.013 · Cited by 60
Liver transplantation for primary biliary cirrhosis
MacQuillan, G. C., & Neuberger, J. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00099-0 · Cited by 60
Remmel, T., Remmel, H., Uibo, R., & Salupere, V. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509093292 · Cited by 58
Kuroki, T., Seki, S., Kawakita, N., Nakatani, K., Kitada, T., Sakaguchi, H., & Hisa, T. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192434 · Cited by 58
Mason, A. L., Lindor, K., Bacon, B. R., Vincent, C., Neuberger, J., & Wasilenko, S. T. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03799.x · Cited by 58
Development of autoimmune hepatitis in primary biliary cirrhosis
Gossard, A. A., & Lindor, K. D. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01538.x · Cited by 57
Joplin, R., Lindsay, G. J., Hübscher, S. G., Johnson, G. D., Shaw, J. C., Strain, A. J., & Neuberger, J. (1991) · Hepatology · doi:10.1002/hep.1840140307 · Cited by 57
Koch, A., Brahm, J., Antezana, C., Smok, G., & Cumsille, M. A. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80294-2 · Cited by 57
X Monosomy in Female Systemic Lupus Erythematosus
Invernizzi, P., Miozzo, M. R., Oertelt‐Prigione, S., Meroni, P. L., Persani, L., Selmi, C. F., Battezzati, P. M., Zuin, M. G., Lucchi, S., Marasini, B., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.010 · Cited by 54
Corpechot, C., Poujol‐Robert, A., Wendum, D., Galotte, M., Chrétien, Y., Poupon, R. E., & Poupon, R. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0918.x · Cited by 48
Self-citationGeographic Clusters of Primary Biliary Cirrhosis
Abu‐Mouch, S., Selmi, C. F., Benson, G. D., Kenny, T. P., Invernizzi, P., Zuin, M. G., Podda, M., Rossaro, L., & Gershwin, M. E. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001626526 · Cited by 48
New insights on the molecular and cell biology of human cholangiopathies
Alvaro, D., & Mancino, M. G. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.007 · Cited by 48
Johal, H., Scott, G. M., Jones, R. M., Camaris, C., Riordan, S. M., & Rawlinson, W. D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.026 · Cited by 47
Fatigue is not a specific symptom in patients with primary biliary cirrhosis
rnsson, E. S. B., Simrén, M., Olsson, R., & Chapman, R. W. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200503000-00015 · Cited by 44
Neuberger, J., & Bradwell, A. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00322-7 · Cited by 44
Walker, L. J., Newton, J. L., Jones, D. E. J., & Bassendine, M. F. (2008) · Hepatology · doi:10.1002/hep.22670 · Cited by 43
Regulation of Cholangiocyte Secretion
Fitz, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-34502 · Cited by 42
Onori, P., Alvaro, D., Floreani, A., Mancino, M. G., Franchitto, A., Guido, M., Carpino, G., Santis, A. D., Angelico, M., Attili, A. F., et al. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6r7125.2006 · Cited by 42
Kurihara, T., Akimoto, M., Abe, K., Ishiguro, H., Niimi, A., Maeda, A., Shigemoto, M., Yamashita, K., Yokoyama, I., & Suzuki, Y. (1993) · PubMed · Cited by 41
Fatigue in Primary Biliary Cirrhosis
Newton, J. L. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.010 · Cited by 40
Molecular mechanisms of cholangiopathy in primary biliary cirrhosis
Harada, K., & Nakanuma, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0321-z · Cited by 39
Animal Models of Primary Biliary Cirrhosis
Chuang, Y., Ridgway, W. M., Ueno, Y., & Gershwin, M. E. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.011 · Cited by 39
Walden, H. R., Kirby, J. A., Yeaman, S. J., Gray, J., Jones, D. E., & Palmer, J. M. (2008) · Hepatology · doi:10.1002/hep.22540 · Cited by 38
Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis
Eliasson, E., Gardner, I. B., Hume‐Smith, H., de Waziers, I., Beaune, P. H., & Kenna, J. G. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00081-7 · Cited by 38
Rubbia‐Brandt, L., Philippeaux, M.-M., Chavez, S., Mentha, G., Borisch, B., & Hadengue, A. (1999) · Hepatology · doi:10.1002/hep.510300322 · Cited by 38
Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan
Ohba, K., Omagari, K., Kinoshita, H., Soda, H., Masuda, J.-I., Hazama, H., Tagawa, M., Hata, T., Nakamura, H., Murata, I., et al. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00370-x · Cited by 37
Donaldson, P. T., Veeramani, S., Baragiotta, A. M., Floreani, A., Venturi, C., Pearce, S. H. S., Wilson, V., Jones, D., James, O., Taylor, J. J., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.012 · Cited by 36
Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis
Allina, J., Stanca, C. M., Garber, J. J., Hu, B., Sautès‐Fridman, C., Bach, N., & Odin, J. A. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.10.003 · Cited by 32
Modafinil for the treatment of fatigue in primary biliary cirrhosis
Kaplan, M. M., & Bonis, P. A. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00024 · Cited by 30
Barwick, K. R., Nakanuma, Y., Saito, K., & Unoura, M. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199006000-00029 · Cited by 30
Babatin, M. A., Sanai, F. M., & Swain, M. G. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03048.x · Cited by 29
AHRENS, E. H., Payne, M., Kunkel, H. G., EISENMENGER, W. J., & Blondheim, D. S. (1964) · New England Journal of Medicine · doi:10.1056/nejm196411262712214 · Cited by 29
Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases
Ballot, E., Bandin, O., Chazouillères, O., Johanet, C., & Poupon, R. Y. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2003.11.002 · Cited by 28
Self-citationGenetics and Genomics of Primary Biliary Cirrhosis
Juran, B. D., & Lazaridis, K. N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.007 · Cited by 27
Treatment of Primary Biliary Cirrhosis: Therapy with Choleretic and Immunosuppressive Agents
Silveira, M. G., & Lindor, K. D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.008 · Cited by 27
Corpechot, C., & Poupon, R. Y. (2007) · Hepatology · doi:10.1002/hep.21871 · Cited by 25
Self-citationThe mystery of primary biliary cirrhosis in British Columbia’s First Nations people
Arbour, L. T., Field, L., Ross, P. J., Erikson, A., & Yoshida, E. M. (2004) · International Journal of Circumpolar Health · doi:10.3402/ijch.v63i0.17896 · Cited by 22
Future Treatment Options in PBC
Vierling, J. M. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916326 · Cited by 14
Targeting Farnesoid X Receptor in Hepatic and Biliary Inflammatory Diseases
Chignard, N., & Poupon, R. Y. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.027 · Cited by 11
Self-citationTsuboi, K. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00170-5 · Cited by 10
Silveira, M. G. (2014) · Clinical gastroenterology · doi:10.1007/978-1-4939-1013-7_3 · Cited by 9
Cited by
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
Self-citationMechanisms of bile acid mediated inflammation in the liver
Li, M., Cai, S.-Y., & Boyer, J. L. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.06.001 · Cited by 271
Ursodeoxycholic acid for primary biliary cirrhosis
Rudic, J. S., Poropat, G., Krstic, M. N., Bjelakovic, G., & Gluud, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000551.pub3 · Cited by 270
Banales, J. M., Sáez, E., Úriz, M., Sarvide, S., Urribarri, A. D., Splinter, P., Tietz Bogert, P. S., Bujanda, L., Prieto, J., Medina, J. F., et al. (2012) · Hepatology · doi:10.1002/hep.25691 · Cited by 250
Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation
Poupon, R. (2015) · Hepatology · doi:10.1002/hep.27715 · Cited by 120
Self-citation
Metadata
- Authors
- Poupon, R.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 52
- Issue
- 5
- Pages
- 745-758
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2088633095
- Cited by
- 274
- References
- 202
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.